|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/557 | (2006.01) |
| A61K 31/5585 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2461812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10739941.2 |
| Date of filing the European patent application | 2010-08-05 | |
| (97) | Date of publication of the European application | 2012-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-01 |
| (46) | Date of publication of the claims translation | 2014-04-25 |
| (86) | Number | PCT/EP2010/061428 |
| Date | 2010-08-05 |
| (87) | Number | WO 2011/015630 |
| Date | 2011-02-10 |
| (30) | Number | Date | Country code |
| 09167491 | 2009-08-07 | EP |
| (72) |
FREISSMUTH, Michael, AT
KOENIG, Xaver, AT
GLOECKEL, Christina, AT
|
| (73) |
SciPharm SaRL,
26-28, rue Edward Steichen, 2540 Luxembourg,
LU
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Kompozicija cistinės fibrozės gydymui |
| COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS |
| Payment date | Validity (years) | Amount | |
| 2021-07-26 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-05 |